• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

    1.400 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,984
    Open 1.400
    Bid (Size) 1.400 (400)
    Ask (Size) 1.430 (2,500)
    Prev. Close 1.400
    Today's Range 1.400 - 1.400
    52wk Range 1.010 - 8.080
    Shares Outstanding 19,996,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Levi & Korsinsky, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of BioXcel Therapeutics, Inc.
    From Levi & Korsinsky, LLP
    Via GlobeNewswire
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill

    Performance

    YTD
    -17.6%
    -17.6%
    1 Month
    +17.6%
    +17.6%
    3 Month
    +15.7%
    +15.7%
    6 Month
    -10.3%
    -10.3%
    1 Year
    -22.7%
    -22.7%

    More News

    Read More
    News headline image
    Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗
    Via Stocktwits
    BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗
    Via Stocktwits
    BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug ↗
    Via Stocktwits
    News headline image
    Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank? ↗
    Via Benzinga
    News headline image
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Which stocks are experiencing notable movement on Wednesday? ↗
    Via Chartmill
    News headline image
    BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment ↗
    Via Benzinga
    News headline image
    The market is filled with gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
    Via Chartmill
    News headline image
    Tuesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On? ↗
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is BioXcel Therapeutics, Inc. - Common Stock publicly traded?
    Yes, BioXcel Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does BioXcel Therapeutics, Inc. - Common Stock trade on?
    BioXcel Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for BioXcel Therapeutics, Inc. - Common Stock?
    The ticker symbol for BioXcel Therapeutics, Inc. - Common Stock is BTAI on the Nasdaq Stock Market
    What is the current price of BioXcel Therapeutics, Inc. - Common Stock?
    The current price of BioXcel Therapeutics, Inc. - Common Stock is 1.400
    When was BioXcel Therapeutics, Inc. - Common Stock last traded?
    The last trade of BioXcel Therapeutics, Inc. - Common Stock was at 06/29/26 04:00 PM ET
    What is the market capitalization of BioXcel Therapeutics, Inc. - Common Stock?
    The market capitalization of BioXcel Therapeutics, Inc. - Common Stock is 27.99M
    How many shares of BioXcel Therapeutics, Inc. - Common Stock are outstanding?
    BioXcel Therapeutics, Inc. - Common Stock has 28M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.